Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001214659-25-016717·Dianthus Therapeutics, Inc. /DE/
Schedule 13G ownership disclosure
DIANTHUS THERAPEUTICS INC COM
Common Stock, $0.001 par value · CUSIP: 252828108
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Octagon Capital Advisors LP
Shares: 2,416,667.00 · Class: 6.1%
- Octagon Investments Master Fund LP
Shares: 2,125,000.00 · Class: 5.3%
- Octagon Private Opportunities Fund II LP
Shares: 291,667.00 · Class: 0.7%
- Ting Jia
Shares: 2,416,667.00 · Class: 6.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-25-016717
- Form type
- SCHEDULE 13G/A
- Filer
- Dianthus Therapeutics, Inc. /DE/
- CIK
- CIK 1690585
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership